Global Biopharmaceutical Business IntelligenceIdentify and evaluate commercial opportunitiesBranded and generic drug pipeline forecastingAnticipate future revenue eventsIdentify API and finished drug product suppliers Try it FreeSee Plans and PricingFind Generic Drug Entry OpportunitiesInform portfolio management decisionsSector landscaping and due diligenceTrack investigational drugs and explore new indications for existing drugsGet Confidential Royalty and Settlement TermsStudy failed patent challenges to develop a better strategyCollect competitive intelligence by examining contractual disputesTrack litigation to anticipate early generic entry Try it FreeSee Plans and PricingFind and Evaluate Business OpportunitiesAssess levels of generic competitionUse drug price ranges to evaluate price elasticityDetermine optimal prices before launchAutomated Reports Custom DashboardsDo more with less staffTake the load off your teamAutomate processes and focus on growing your business Try it FreeSee Plans and PricingRefine Your Market-Entry StrategyAssess market potential through historic sales figuresEvaluate buyer power with data on reimbursement segmentationAlign distribution methods with information on where and how drugs are purchasedGlobal Drug PatentsDrug Patents in 134 CountriesEvaluate branded and generic market opportunities globally Try it FreeSee Plans and PricingMonitor biosimilar and 505(b)(2) activityAnticipate 505(b)(2) and biosimilar approvalsTrack OTC-switches, new formulations, biosimilars, and other drug improvementsStrengthen new formulation patents by studying prior claims and litigation